News Roundup: CBD, Artificial Intelligence in Pharmacy
Here’s a roundup of the latest news coverage from Drug Topics®.
CBD Legislation Remains in Limbo
Selling CBD can be profitable for pharmacies, if they follow regulatory guidelines.
https://www.drugtopics.com/view/cbd-legislation-remains-in-limbo
Good Neighbor Pharmacy Reflects on the Success of the Federal Retail Pharmacy Program
Good Neighbor Pharmacy (GNP) has allocated more than 2 million doses of COVID-19 vaccines to more than 1500 independent pharmacies through its partnership with the Federal Retail Pharmacy Program.
Boosting Confidence in CBD Counseling
How to discuss CBD and answer questions frequently asked by patients
https://www.drugtopics.com/view/boosting-confidence-in-cbd-counseling
Artificial Intelligence Has Come in Waves
Artificial intelligence has been an integral part of pharmacy for decades. It is called the pharmacy management system: the collection of digital tools that houses patient utilization and drug data in virtually all pharmacy settings.
https://www.drugtopics.com/view/artificial-intelligence-used-in-pharmacy-has-come-in-waves
Challenges and Opportunities Facing Independent Community Pharmacies
AmerisourceBergen and Good Neighbor Pharmacy are working to support policies that will help advance the pharmacy profession.
https://www.drugtopics.com/view/challenges-and-opportunities-facing-independent-community-pharmacies
Ovarian Cancer Treatment Update and Pharmacists' Role
New targeted therapies known as PARP inhibitors (PARPis) used to treat patients with advanced ovarian cancer are transforming the treatment landscape through precision medicine.
https://www.drugtopics.com/view/ovarian-cancer-treatment-update-and-pharmacists-role
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
Examining Impact of COVID-19 Diagnosis Timing on AF Progression | AHA 2024
November 21st 2024“[O]ur data do not support the hypothesis that early COVID resulted in more significant structural or electrical cardiac remodeling that would increase the likelihood of atrial fibrillation progression,” the authors said.
